BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 16107246)

  • 1. Management strategies for patients with hereditary pancreatic cancer.
    Brentnall TA
    Curr Treat Options Oncol; 2005 Sep; 6(5):437-45. PubMed ID: 16107246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial pancreatic cancer: Concept, management and issues.
    Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T
    World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
    Aslanian HR; Lee JH; Canto MI
    Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and Management of Hereditary Pancreatic Cancer.
    Humphris JL; Biankin AV
    Recent Results Cancer Res; 2016; 205():61-83. PubMed ID: 27075349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hereditary pancreatic cancer].
    Habbe N; Langer P; Bartsch DK
    Chirurg; 2008 Nov; 79(11):1029-37. PubMed ID: 18818893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial pancreatic cancer: challenging diagnostic approach and therapeutic management.
    Mastoraki A; Chatzimavridou-Grigoriadou V; Chatzipetrou V; Mastoraki S; Papanikolaou IS; Danias N; Smyrniotis V; Arkadopoulos N
    J Gastrointest Cancer; 2014 Sep; 45(3):256-61. PubMed ID: 24756831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneļ¬cial?
    Torphy RJ; Schulick RD
    Surg Clin North Am; 2018 Feb; 98(1):25-35. PubMed ID: 29191275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of age of onset in pancreatic cancer kindreds.
    Brune KA; Lau B; Palmisano E; Canto M; Goggins MG; Hruban RH; Klein AP
    J Natl Cancer Inst; 2010 Jan; 102(2):119-26. PubMed ID: 20068195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited pancreatic cancer: improvements in our understanding of genetics and screening.
    Rulyak SJ; Brentnall TA
    Int J Biochem Cell Biol; 2004 Aug; 36(8):1386-92. PubMed ID: 15147717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance for neoplasia in the pancreas.
    Overbeek KA; Cahen DL; Canto MI; Bruno MJ
    Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):971-986. PubMed ID: 27938791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer surveillance of patients from familial pancreatic cancer kindreds.
    Brentnall TA
    Med Clin North Am; 2000 May; 84(3):707-18. PubMed ID: 10872427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited pancreatic cancer: surveillance and treatment strategies for affected families.
    Rulyak SJ; Brentnall TA
    Pancreatology; 2001; 1(5):477-85. PubMed ID: 12120228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.
    Kasuga A; Okamoto T; Udagawa S; Mori C; Mie T; Furukawa T; Yamada Y; Takeda T; Matsuyama M; Sasaki T; Ozaka M; Ueki A; Sasahira N
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial Pancreatic Cancer and the Future of Directed Screening.
    Welinsky S; Lucas AL
    Gut Liver; 2017 Nov; 11(6):761-770. PubMed ID: 28609837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial pancreatic cancer--status quo.
    Fendrich V; Langer P; Bartsch DK
    Int J Colorectal Dis; 2014 Feb; 29(2):139-45. PubMed ID: 23948969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heritable Gastrointestinal Cancer Syndromes.
    Stoffel EM
    Gastroenterol Clin North Am; 2016 Sep; 45(3):509-27. PubMed ID: 27546846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
    Daly MB; Pilarski R; Yurgelun MB; Berry MP; Buys SS; Dickson P; Domchek SM; Elkhanany A; Friedman S; Garber JE; Goggins M; Hutton ML; Khan S; Klein C; Kohlmann W; Kurian AW; Laronga C; Litton JK; Mak JS; Menendez CS; Merajver SD; Norquist BS; Offit K; Pal T; Pederson HJ; Reiser G; Shannon KM; Visvanathan K; Weitzel JN; Wick MJ; Wisinski KB; Dwyer MA; Darlow SD
    J Natl Compr Canc Netw; 2020 Apr; 18(4):380-391. PubMed ID: 32259785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.
    Canto MI; Harinck F; Hruban RH; Offerhaus GJ; Poley JW; Kamel I; Nio Y; Schulick RS; Bassi C; Kluijt I; Levy MJ; Chak A; Fockens P; Goggins M; Bruno M;
    Gut; 2013 Mar; 62(3):339-47. PubMed ID: 23135763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.